FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kholoud Porter

Research Profile

Disorders

Procedures

Concepts & Ideas

Living Beings

Phenomena

HIV Seropositivity

Chemicals & Drugs

Geographic Areas

Physiology

Co-author Network

Publications

TOP 3
Jannie van der Helm; Geneviève Chêne; Julia Del Amo; Maria Dorrucci; Ronald B Geskus; Laurence Meyer; Roberto Muga; Kholoud Porter; Maria Prins; Caroline Sabin
Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
Kholoud Porter; Sara Lodi; Laurence Meyer
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply.
Giota Touloumi; Robert Zangerle; Heiner C Bucher; Marie-Laure Chaix; Anne-Marte Bakken Kran; Claudia Kücherer; Nikos Pantazis; Dimitrios Paraskevis; Deenan Pillay; Kholoud Porter
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kholoud Porter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jannie van der Helm; Geneviève Chêne; Julia Del Amo; Maria Dorrucci; Ronald B Geskus; Laurence Meyer; Roberto Muga; Kholoud Porter; Maria Prins; Caroline Sabin
Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
Gastroenterology 2013;144(4):751-760.e2.
2013: Kholoud Porter; Sara Lodi; Laurence Meyer
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply.
JAMA internal medicine 2013;173(6):476-7.
2013: Giota Touloumi; Robert Zangerle; Heiner C Bucher; Marie-Laure Chaix; Anne-Marte Bakken Kran; Claudia Kücherer; Nikos Pantazis; Dimitrios Paraskevis; Deenan Pillay; Kholoud Porter
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(6):888-97.
2013: Sara Lodi; Charles Morrison; Roberto Muga; Kholoud Porter; Caroline Sabin; Sophie Abgrall; Antonella d'Arminio Monforte; Julia del Amo; Hansjakob Furrer; Enrico Girardi
Risk of tuberculosis following HIV seroconversion in high-income countries.
Thorax 2013;68(3):207-13.
2013: David Cooper; Fiona Ewings; Sarah Fidler; Martin Fisher; John Frater; Michelle Gabriel; Pontiano Kaleebu; Steve Kaye; Anthony Kelleher; Sabine Kinloch; Myra McClure; Jose M Miro; Rodney Phillips; Kholoud Porter; Gita Ramjee; Helen Rees; Mauro Schechter; Giuseppe Tambussi; Jonathan Weber; Abdel Babiker
Short-course antiretroviral therapy in primary HIV infection.
The New England journal of medicine 2013;368(3):207-17.
2012: Susan Hoskins; Andreas Jahn; Pontiano Kaleebu; Wilford Kirungi; Ruslan N. Malyuta; Sam Phiri; Igor Semenenko; Geoffrey Somi; Ian Weller; Ade Fakoya; Kholoud Porter
Evaluating the systems used to monitor HIV populations accessing therapy and care in low-income and lower-middle-income countries.
AIDS (London, England) 2012;26 Suppl 2():S137-45.
2012: Joanna Smoleń-Dzirba; Bartosz Szetela; Marek Beniowski; Monika Bociąga-Jasik; Jolanta Bratosiewicz-Wąsik; Elżbieta Jabłonowska; Janusz Janiec; Piotr Kruszyński; Kholoud Porter; Magdalena Rosińska; Tomasz J Wąsik
Molecular epidemiology of recent HIV-1 infections in southern Poland.
Journal of medical virology 2012;84(12):1857-68.
2012: Sara Lodi; Laurence Meyer; Jade Ghosn; Anthony D Kelleher; Magdalena Rosinska; Mette Sannes; Kholoud Porter
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.
Archives of internal medicine 2012;172(16):1252-5.
2012: Elizabeth Hamlyn; Stephen Hickling; Steve Kaye; Nicola E Mackie; Myra McClure; Rodney Phillips; Kholoud Porter; Mark Robinson; Sarah Fidler; John Frater
Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.
AIDS (London, England) 2012;26(7):887-90.
2012: Elizabeth Hamlyn; Myra McClure; Jason F Okulicz; Court Pedersen; Kholoud Porter; Mauro Schechter; Giuseppe Tambussi; Jonathan Weber; Abdel Babiker; David A Cooper; Fiona M Ewings; Sarah Fidler
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.
PloS one 2012;7(8):e43754.
2012: Daniela Zugna; Abdel Babiker; Barbara Bartmeyer; Faroudy Boufassa; Marie-Laure Chaix; Bianca De Stavola; Ronald B Geskus; Kholoud Porter; Magdalena Rosinska
Time to virological failure, treatment change and interruption for individuals treated within 12 months of HIV seroconversion and in chronic infection.
Antiviral therapy 2012;17(6):1039-48.
2012: Joseph O Mugisha; Kholoud Porter; Gita Ramjee; Katherine Donegan; David T Dunn; Sarah Fidler; Andrew Hodson; Jennifer Serwanga
Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults.
The open AIDS journal 2012;6():45-52.
2012: Nikos Pantazis; Kholoud Porter; Robert A Salata; Giota Touloumi; Pauli N Amornkul; Tsungai Chipato; Harold Jaffe; Etienne Karita; Shabir Lakhi; Charlotte Lewden; Laurence Meyer; Albert Minga; Charles Morrison
Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
PloS one 2012;7(3):e32369.
2011: Sara Lodi; Laurence Meyer; Nikos Pantazis; Andrew Phillips; Kholoud Porter; Rodolphe Thiébaut; Giota Touloumi; Julia Del Amo; Abdel Babiker; Ronald Geskus; Anne M Johnson
Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(8):817-25.
2011: Harold W Jaffe; Kholoud Porter; Lucy M Carpenter; David R Cox; Bianca L De Stavola
Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
AIDS (London, England) 2011;25(11):1395-403.
2011: Jannie J van der Helm; Heiner C Bucher; Geneviève Chêne; Julia del Amo; Maria Dorrucci; Ronald B Geskus; John Gill; Osamah Hamouda; Kholoud Porter; Maria Prins; Mette Sannes
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007.
AIDS (London, England) 2011;25(8):1083-91.
2011: Cristina Mussini; Kholoud Porter; Giovanni Rezza; Caroline Sabin; Abdel Babiker; Heiner C Bucher; Andrea Cossarizza; Andrea De Luca; Maria Dorrucci; Martin Fisher
Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.
AIDS (London, England) 2011;25(8):1041-9.
2011: Linda Wittkop; Andrea Antinori; Hannah Castro; Geneviève Chêne; Bonaventura Clotet; Céline Colin; Alessandro Cozzi-Lepri; Andrea de Luca; Frank de Wolf; David Dunn; Federico García; Huldrych F Günthard; Ali Judd; Jesper Kjaer; Claudia Kücherer; Jens D Lundgren; Bernard Masquelier; Niels Obel; Roger Paredes; Andrew Phillips; Deenan Pillay; Kholoud Porter; Anton Pozniak; Christoph Stephan; Rodolphe Thiébaut; Carlo Torti; Ard I van Sighem; Viktor von Wyl
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
The Lancet infectious diseases 2011;11(5):363-71.
2011: Lucy Garvey; Alan Winston; John Walsh; Frank Post; Kholoud Porter; Brian Gazzard; Martin Fisher; Clifford Leen; Deenan Pillay; Teresa Hill; Margaret Johnson; Richard Gilson; Jane Anderson; Philippa Easterbrook; Loveleen Bansi; Chloe Orkin; Jonathan Ainsworth; Andrew N Phillips; Caroline A Sabin
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(3):527-34.
2011: L Garvey; Alan Winston; J Walsh; F Post; Kholoud Porter; Brian Gazzard; Martin Fisher; C Leen; D Pillay; T Hill; M Johnson; R Gilson; J Anderson; Philippa Easterbrook; L Bansi; C Orkin; J Ainsworth; A Palfreeman; M Gompels; A N Phillips; C A Sabin
Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease.
Neurology 2011;76(8):693-700.
2011: Margaret May; Mark Nelson; Chloe Orkin; Adrian Palfreeman; Andrew Phillips; Kholoud Porter; Frank Post; Jonathan Ainsworth; Jane Anderson; Loveleen Bansi; Valerie Delpech; David Dunn; Martin Fisher; Brian Gazzard; Richard Gilson; Mark Gompels; Teresa Hill; Margaret Johnson; Clifford Leen; John Walsh; Caroline Sabin
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.
BMJ (Clinical research ed.) 2011;343():d6016.
2010: Sara Lodi; Andrew Phillips; Giota Touloumi; Nikos Pantazis; Heiner C Bucher; Abdel Babiker; Geneviève Chêne; Philippe Vanhems; Kholoud Porter
CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era.
AIDS (London, England) 2010;24(17):2697-704.
2010: Susan Hoskins; Ian Weller; Andreas Jahn; Pontiano Kaleebu; Ruslan N. Malyuta; Wilford Kirungi; Ade Fakoya; Kholoud Porter
An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries.
AIDS (London, England) 2010;24(17):2603-7.
2010: Heiner C Bucher; Marcel Wolbers; Kholoud Porter
2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2010;304(17):1897; author reply 1897-8.
2010: Rebecca K Lodwick; Caroline A Sabin; Kholoud Porter; bruno ledergerber; Ard van Sighem; Alessandro Cozzi-Lepri; Pavel Khaykin; Amanda Mocroft; Lisa P Jacobson; Stephane De Wit; Niels Obel; Antonella Castagna; Jan-Christian Wasmuth; John Gill; Marina B Klein; Stephen J Gange; Melchor Riera; Cristina Mussini; Félix Gutiérrez; Giota Touloumi; Patrizia Carrieri; Jodie L Guest; Norbert H Brockmeyer; Andrew N Phillips
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
Lancet 2010;376(9738):340-5.
2010: Elizabeth Hamlyn; Vicky Jones; Kholoud Porter; Sarah Fidler
Antiretroviral treatment of primary HIV infection to reduce onward transmission.
Current opinion in HIV and AIDS 2010;5(4):283-90.
2010: Sara Lodi; Marguerite Guiguet; Dominique Costagliola; Martin Fisher; Andrea de Luca; Kholoud Porter
Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.
Journal of the National Cancer Institute 2010;102(11):784-92.
2010: Loveleen Bansi; Anna Maria Geretti; David Dunn; Teresa Hill; Hannah Green; Esther Fearnhill; Brian Gazzard; Mark Nelson; Kholoud Porter; Andrew Phillips; Caroline Sabin
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART).
Journal of acquired immune deficiency syndromes (1999) 2010;53(5):633-9.
2010: Caroline A Sabin; Achim Schwenk; Margaret A Johnson; Brian Gazzard; Martin Fisher; John Walsh; Chloe Orkin; Teresa Hill; Richard Gilson; Kholoud Porter; Philippa Easterbrook; Valerie Delpech; Loveleen Bansi; Clifford Leen; Mark Gompels; Jane Anderson; Andrew N Phillips
Late diagnosis in the HAART era: proposed common definitions and associations with mortality.
AIDS (London, England) 2010;24(5):723-7.
2010: Marcel Wolbers; Abdel Babiker; Caroline Sabin; Jim Young; Maria Dorrucci; Geneviève Chêne; Cristina Mussini; Kholoud Porter; Heiner C Bucher
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
PLoS medicine 2010;7(2):e1000239.
2010: R J C Gilson; S-L Man; Andrew J Copas; A Rider; S Forsyth; Teresa Hill; L Bansi; Kholoud Porter; B Gazzard; C Orkin; Deenan Pillay; A Schwenk; Margaret Johnson; P Easterbook; J Walsh; Martin Fisher; Clifford Leen; Jane Anderson; Caroline A Sabin
Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study.
HIV medicine 2010;11(2):152-60.
2009: Alison D Grant; Loveleen Bansi; Jonathan Ainsworth; Jane Anderson; Valerie Delpech; Philippa Easterbrook; Martin Fisher; Brian Gazzard; Richard Gilson; Mark Gompels; Teresa Hill; Margaret Johnson; Clifford Leen; Chloe Orkin; Andrew N Phillips; Kholoud Porter; Frank Post; John Walsh; Caroline A Sabin
Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?
AIDS (London, England) 2009;23(18):2507-15.
2009: Loveleen Bansi; Jo Turner; Richard Gilson; Frank Post; Brian Gazzard; Clifford Leen; Jane Anderson; Kholoud Porter; Teresa Hill; Martin Fisher; Jonathan Ainsworth; Deenan Pillay; Margaret Johnson; Alan Winston; Chloe Orkin; Philippa Easterbrook; Andrew Phillips; Caroline Sabin
Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):391-6.
2009: Benoît Marin; Rodolphe Thiébaut; Heiner C Bucher; Virginie Rondeau; Dominique Costagliola; Maria Dorrucci; Osamah Hamouda; Maria Prins; Sarah Walker; Kholoud Porter; Caroline Sabin; Geneviève Chêne
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
AIDS (London, England) 2009;23(13):1743-53.
2009: mark bower; Martin Fisher; Teresa Hill; Iain Reeves; John Walsh; Chloe Orkin; Andrew N Phillips; Loveleen Bansi; Richard Gilson; Philippa Easterbrook; Margaret Johnson; Brian Gazzard; Clifford Leen; Deenan Pillay; Achim Schwenk; Jane Anderson; Kholoud Porter; Mark Gompels; Caroline A Sabin
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.
Haematologica 2009;94(6):875-80.
2009: Alison E Brown; Robert James Gifford; Jonathan P Clewley; Claudia Kucherer; Bernard Masquelier; Kholoud Porter; Claudia Balotta; Nicole K T Back; Louise Bruun Jorgensen; Carmen de Mendoza; Krishnan Bhaskaran; O Noel Gill; Anne M Johnson; Deenan Pillay
Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions.
The Journal of infectious diseases 2009;199(3):427-31.
2009: Caroline A Sabin; Colette J Smith; Valerie Delpech; Jane Anderson; L Bansi; Richard Gilson; A Schwenk; Clifford Leen; Brian Gazzard; Kholoud Porter; N Mackie; Martin Fisher; Chloe Orkin; Margaret Johnson; Philippa Easterbrook; Teresa Hill; Andrew N Phillips
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy.
HIV medicine 2009;10(1):35-43.
2008: Giota Touloumi; Nikos Pantazis; Heide A Stirnadel; A Sarah Walker; Faroudy Boufassa; Philippe Vanhems; Kholoud Porter
Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.
Journal of acquired immune deficiency syndromes (1999) 2008;49(5):492-8.
2008: Nikos Pantazis; Giota Touloumi; Philippe Vanhems; John Gill; Heiner C Bucher; Kholoud Porter
The effect of antiretroviral treatment of different durations in primary HIV infection.
AIDS (London, England) 2008;22(18):2441-50.
2008: Vanni Borghi; Enrico Girardi; Stefania Bellelli; Claudio Angeletti; Cristina Mussini; Kholoud Porter; Roberto Esposito
Late presenters in an HIV surveillance system in Italy during the period 1992-2006.
Journal of acquired immune deficiency syndromes (1999) 2008;49(3):282-6.
2008: Katherine J Lee; David Dunn; Richard Gilson; Kholoud Porter; Loveleen Bansi; Teresa Hill; Andrew N Phillips; Caroline A Sabin; Achim Schwenk; Clifford Leen; Valerie Delpech; Jane Anderson; Brian Gazzard; Margaret Johnson; Philippa Easterbrook; John Walsh; Martin Fisher; Chloe Orkin
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study.
AIDS (London, England) 2008;22(15):1943-50.
2008: Inmaculada Jarrin; Ronald Geskus; Krishnan Bhaskaran; Maria Prins; Santiago Perez-Hoyos; Roberto Muga; Ildefonso Hernández-Aguado; Laurence Meyer; Kholoud Porter; Julia del Amo
Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.
American journal of epidemiology 2008;168(5):532-40.
2008: Krishnan Bhaskaran; Osamah Hamouda; Mette Sannes; Faroudy Boufassa; Anne M Johnson; Paul C Lambert; Kholoud Porter
Changes in the risk of death after HIV seroconversion compared with mortality in the general population.
JAMA : the journal of the American Medical Association 2008;300(1):51-9.
2008: David Dunn; Patrick Woodburn; Trinh Duong; Julian Peto; Andrew Phillips; Diana M Gibb; Kholoud Porter
Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults.
The Journal of infectious diseases 2008;197(3):398-404.
2008: Kholoud Porter; Sarah Walker; Teresa Hill; Jane Anderson; Clifford Leen; Margaret Johnson; Brian Gazzard; John Walsh; Martin Fisher; Chloe Orkin; Achim Schwenk; Richard Gilson; Philippa Easterbrook; Valerie Delpech; Caroline A Sabin
Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3.
Journal of acquired immune deficiency syndromes (1999) 2008;47(2):202-5.
2008: Krishnan Bhaskaran; Cristina Mussini; Andrea Antinori; Ann Sarah Walker; Maria Dorrucci; Caroline Sabin; Andrew Phillips; Kholoud Porter
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.
Annals of neurology 2008;63(2):213-21.
2008: Loveleen K Bansi; Andrew A Benzie; Andrew N Phillips; Simon Portsmouth; Teresa Hill; Clifford Leen; Achim Schwenk; Margaret Johnson; Jane Anderson; Richard Gilson; Philippa Easterbrook; Brian Gazzard; Martin Fisher; Chloe Orkin; Kholoud Porter; Deenan Pillay; Graham P Taylor; John C Walsh; Caroline A Sabin
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?
AIDS (London, England) 2008;22(3):349-56.
2008: Fiona M Ewings; Krishnan Bhaskaran; Ken McLean; David Hawkins; Martin Fisher; Sarah Fidler; Richard Gilson; Demelza Nock; Ray Brettle; Margaret Johnson; Andrew Phillips; Kholoud Porter
Survival following HIV infection of a cohort followed up from seroconversion in the UK.
AIDS (London, England) 2008;22(1):89-95.
2008: Marguerite Guiguet; Kholoud Porter; Andrew Phillips; Dominique Costagliola; Abdel Babiker
Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART).
The open AIDS journal 2008;2():3-9.
2007: Andrew N Phillips; Brian Gazzard; Richard Gilson; Philippa Easterbrook; Margaret Johnson; John Walsh; Clifford Leen; Martin Fisher; Chloe Orkin; Jane Anderson; Deenan Pillay; Valerie Delpech; Caroline Sabin; Achim Schwenk; David Dunn; Mark Gompels; Teresa Hill; Kholoud Porter; Abdel G Babiker
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count.
AIDS (London, England) 2007;21(13):1717-21.
2007: W Stöhr; David Dunn; Kholoud Porter; Teresa Hill; Brian Gazzard; John Walsh; Richard Gilson; Philippa Easterbrook; Martin Fisher; Ma Johnson; Valerie Delpech; An Phillips; Caroline Sabin
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003.
HIV medicine 2007;8(3):135-41.
2007: Fiona C Lampe; Kholoud Porter; John Kaldor; Matthew Law; Sabine Kinloch-de-Loes; Andrew N Phillips
Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study.
Antiviral therapy 2007;12(2):189-93.
2006: Deenan Pillay; Krishnan Bhaskaran; Suzanne Jurriaans; Maria Prins; Bernard Masquelier; François Dabis; Robert James Gifford; Claus Nielsen; Court Pedersen; Claudia Balotta; Giovanni Rezza; Marta Ortiz; Carmen de Mendoza; Claudia Kücherer; Gabriele Poggensee; John Gill; Kholoud Porter
The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.
AIDS (London, England) 2006;20(1):21-8.
2006: Daniela Bezemer; Anthony de Ronde; Maria Prins; Kholoud Porter; Robert James Gifford; Deenan Pillay; Bernard Masquelier; Hervé Fleury; François Dabis; Nicole Back; Suzanne Jurriaans; Lia van der Hoek
Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load.
Antiviral therapy 2006;11(2):173-8.
2005: Bernard Masquelier; Krishnan Bhaskaran; Deenan Pillay; Robert James Gifford; Eric Balestre; Louise B Jørgensen; Court Pedersen; Lia van der Hoek; Maria Prins; Claudia Balotta; Benedetta Longo; Claudia Kücherer; Gabriele Poggensee; Marta Ortiz; Carmen de Mendoza; John Gill; Hervé Fleury; Kholoud Porter
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.
Journal of acquired immune deficiency syndromes (1999) 2005;40(5):505-11.
2005: Colette J Smith; Andrew N Phillips; Teresa Hill; Martin Fisher; Brian Gazzard; Kholoud Porter; Richard Gilson; Philippa Easterbrook; Ryanne Matthias; George Scullard; Margaret A Johnson; Caroline A Sabin
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.
The Journal of infectious diseases 2005;192(8):1387-97.
2005: Andrew N Phillips; David Dunn; Caroline Sabin; Anton Pozniak; Ryanne Matthias; Anna Maria Geretti; John Clarke; Duncan Churchill; Ian Williams; Teresa Hill; Hannah Green; Kholoud Porter; George Scullard; Margaret Johnson; Philippa Easterbrook; Richard Gilson; Martin Fisher; Clive Loveday; Brian Gazzard; Deenan Pillay
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.
AIDS (London, England) 2005;19(5):487-94.
2004: Krishnan Bhaskaran; Deenan Pillay; A Sarah Walker; Martin Fisher; David Hawkins; Richard Gilson; Ken McLean; Kholoud Porter
Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters.
AIDS (London, England) 2004;18(10):1471-3.
2004: Kholoud Porter; Basia Zaba
The empirical evidence for the impact of HIV on adult mortality in the developing world: data from serological studies.
AIDS (London, England) 2004;18 Suppl 2():S9-S17.
2004: Krishnan Bhaskaran; Ray Brettle; Kholoud Porter; A Sarah Walker
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
AIDS (London, England) 2004;18(4):673-81.
2003: Kholoud Porter; Abdel Babiker; Krishnan Bhaskaran; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; A Sarah Walker
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
Lancet 2003;362(9392):1267-74.
1999: Kholoud Porter; A M Johnson; A N Phillips; J H Darbyshire
The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK register of HIV seroconverters.
AIDS (London, England) 1999;13(14):1943-51.